Amgen Inc (AMGN)
294.52
+4.62
(+1.59%)
USD |
NASDAQ |
Nov 22, 16:00
294.53
+0.01
(+0.00%)
After-Hours: 20:00
Amgen Free Cash Flow (Quarterly): 3.314B for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 3.314B |
| June 30, 2024 | 2.221B |
| March 31, 2024 | 459.00M |
| December 31, 2023 | 289.00M |
| September 30, 2023 | 2.512B |
| June 30, 2023 | 3.838B |
| March 31, 2023 | 720.00M |
| December 31, 2022 | 2.309B |
| September 30, 2022 | 2.818B |
| June 30, 2022 | 1.684B |
| March 31, 2022 | 1.974B |
| December 31, 2021 | 2.521B |
| September 30, 2021 | 2.176B |
| June 30, 2021 | 1.746B |
| March 31, 2021 | 1.938B |
| December 31, 2020 | 1.98B |
| September 30, 2020 | 3.233B |
| June 30, 2020 | 2.684B |
| March 31, 2020 | 1.992B |
| December 31, 2019 | 2.326B |
| September 30, 2019 | 3.207B |
| June 30, 2019 | 1.27B |
| March 31, 2019 | 1.729B |
| December 31, 2018 | 2.969B |
| September 30, 2018 | 3.102B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.915B |
| March 31, 2018 | 2.572B |
| December 31, 2017 | 2.859B |
| September 30, 2017 | 3.296B |
| June 30, 2017 | 2.141B |
| March 31, 2017 | 2.217B |
| December 31, 2016 | 2.873B |
| September 30, 2016 | 2.594B |
| June 30, 2016 | 2.39B |
| March 31, 2016 | 1.759B |
| December 31, 2015 | 1.868B |
| September 30, 2015 | 2.804B |
| June 30, 2015 | 3.101B |
| March 31, 2015 | 1.364B |
| December 31, 2014 | 2.504B |
| September 30, 2014 | 2.421B |
| June 30, 2014 | 2.054B |
| March 31, 2014 | 970.00M |
| December 31, 2013 | 1.634B |
| September 30, 2013 | 1.632B |
| June 30, 2013 | 1.441B |
| March 31, 2013 | 891.00M |
| December 31, 2012 | 587.00M |
| September 30, 2012 | 1.55B |
| June 30, 2012 | 2.203B |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
289.00M
Minimum
Dec 2023
3.838B
Maximum
Jun 2023
2.137B
Average
2.198B
Median
Free Cash Flow (Quarterly) Benchmarks
| Johnson & Johnson | 5.714B |
| Eli Lilly and Co | -458.90M |
| Merck & Co Inc | 8.508B |
| Regeneron Pharmaceuticals Inc | 1.049B |
| Viking Therapeutics Inc | -21.96M |